Individualized Treatment Strategy for Depressive Disorder
- 30 November 2019
- book chapter
- Published by Springer Nature
- Vol. 1180, 219-232
Abstract
The goal of treatment for depressive disorders is complete remission of depressive symptoms with full recovery of social function and prevention of recurrence. However, a large proportion of patients do not experience symptomatic remission after the initial treatment, with even lower rates of remission in the longer treatment term. The main objective of individualized treatment applied in psychiatry is to improve precision in disease diagnosis, prognosis, treatment choices, and treatment response. Diverse approaches and techniques, such as genomics, epigenomics, other omics, neural circuit, and artificial intelligence are related to precision psychiatry. Using biology and computational psychiatry tools to find potential biomarkers, and based on precision psychiatry, patients considered to belong to the same endophenotype will be possible to receive biomarkers-based treatment and better prognosis. Especially in the choice of intervention, individualized treatment should be considered. In this review, we present the development of precise treatment in depressive disorders and introduce advances in several domains toward precision medicine and individualized treatment. We pay particular attention to biomarkers and the development of new technologies in depressive disorders, which will help disease complete remission and functional recovery, seek better lives for patients suffered with depressive disorders.Keywords
This publication has 70 references indexed in Scilit:
- DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEPTranslational Psychiatry, 2013
- Genome-wide association studies of antidepressant outcome: A brief reviewProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2011
- CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research NetworkClinical Pharmacology & Therapeutics, 2011
- Reconsidering anhedonia in depression: Lessons from translational neuroscienceNeuroscience & Biobehavioral Reviews, 2011
- Resting-state functional MRI in depression unmasks increased connectivity between networks via the dorsal nexusProceedings of the National Academy of Sciences, 2010
- The Reward Circuit: Linking Primate Anatomy and Human ImagingNeuropsychopharmacology, 2009
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and ImplicationsBiological Psychiatry, 2008
- Selective Loss of Brain-Derived Neurotrophic Factor in the Dentate Gyrus Attenuates Antidepressant EfficacyBiological Psychiatry, 2008
- Primary Versus Specialty Care Outcomes for Depressed Outpatients Managed with Measurement-Based Care: Results from STAR*DJournal of General Internal Medicine, 2008